FPP Announces the Filing of its First Organically Developed ANDA

Share Article

Florida Pharmaceutical Products, LLC, (FPP), a pharmaceutical company involved in the Development, Sales, Marketing, and Distribution of Generic Pharmaceuticals is pleased to announce the filing of its first organically developed ANDA with the FDA. Currently the market for this product has sales of approximately $100 million according to IQVIA™ and limited generic competition.

The product that was just filed is one of the original pipeline product selections of the founder, the late Larry Runsdorf. "We are excited about this opportunity and happy to bring this project to filing, in honor of what Larry started several years ago," said Larry J. Lapila, President of FPP.

About Florida Pharmaceutical Products, LLC:

Florida Pharmaceutical Products, LLC, (FPP), is a Boca Raton-based pharmaceutical company involved in the development of Generic Pharmaceuticals seeking to gain approval and/or license of niche generic products in a broad range of therapeutic areas for marketing and distribution in the US.

At FPP our mission is to deliver products to improve patients' lives.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Gina Campbell
Florida Pharmaceutical Products, LLC
+1 561-609-3240
Email >
Visit website